{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:37:51Z","timestamp":1781246271926,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bbrc.2025.151325","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T07:23:06Z","timestamp":1736752986000},"page":"151325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Plumbagin ameliorates renal fibrosis by suppressing epithelial-mesenchymal transition"],"prefix":"10.1016","volume":"750","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9873-9537","authenticated-orcid":false,"given":"Hyunsik","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Geun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9366-3863","authenticated-orcid":false,"given":"Jung-Yoon","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.151325_bib1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.151325_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1172\/JCI93563","article-title":"Resolution of organ fibrosis","volume":"128","author":"Jun","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2025.151325_bib3","first-page":"467","article-title":"Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair","volume":"17","author":"Weber","year":"1997","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.bbrc.2025.151325_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101191","article-title":"Mechanisms of organ fibrosis: emerging concepts and implications for novel treatment strategies","volume":"92","author":"Lurje","year":"2023","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.bbrc.2025.151325_bib5","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/CCM.0b013e31822f09d7","article-title":"Mechanical stress induces lung fibrosis by epithelial-mesenchymal transition","volume":"40","author":"Cabrera-Benitez","year":"2012","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbrc.2025.151325_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2023.151288","article-title":"Mechanical stress regulates the mechanotransduction and metabolism of cardiac fibroblasts in fibrotic cardiac diseases","volume":"102","author":"Tian","year":"2023","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.bbrc.2025.151325_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fphar.2014.00123","article-title":"Fibroblasts in fibrosis: novel roles and mediators","volume":"5","author":"Kendall","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.151325_bib8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41580-024-00716-0","article-title":"Fibroblast and myofibroblast activation in normal tissue repair and fibrosis","volume":"25","author":"Younesi","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2025.151325_bib9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41581-022-00590-z","article-title":"The fibrogenic niche in kidney fibrosis: components and mechanisms","volume":"18","author":"Li","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bbrc.2025.151325_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","article-title":"Kidney fibrosis: from mechanisms to therapeutic medicines","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2025.151325_bib11","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4155\/fmc-2020-0005","article-title":"TGF-beta in renal fibrosis: triumphs and challenges","volume":"12","author":"Gu","year":"2020","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bbrc.2025.151325_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010408","article-title":"Fibrosis in chronic kidney disease: pathogenesis and consequences","volume":"22","author":"Panizo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.151325_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11154-008-9100-6","article-title":"3rd, New insights into the mechanisms of fibrosis and sclerosis in diabetic nephropathy","volume":"9","author":"Brosius","year":"2008","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.bbrc.2025.151325_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214317","article-title":"Renal fibrosis in lupus nephritis","volume":"23","author":"Sciascia","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.151325_bib15","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7150\/ijms.91804","article-title":"Development and validation of a diagnostic nomogram to evaluate tubular atrophy\/interstitial fibrosis of IgA nephropathy","volume":"21","author":"Gan","year":"2024","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bbrc.2025.151325_bib16","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/s41419-018-1157-x","article-title":"Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury","volume":"9","author":"Qi","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2025.151325_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-981-13-8871-2_11","article-title":"How tubular epithelial cell injury contributes to renal fibrosis","volume":"1165","author":"Liu","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbrc.2025.151325_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.01.001","article-title":"Renal tubular epithelial cell quality control mechanisms as therapeutic targets in renal fibrosis","volume":"14","author":"Bao","year":"2024","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.bbrc.2025.151325_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00441-011-1227-1","article-title":"The role of EMT in renal fibrosis","volume":"347","author":"Carew","year":"2012","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbrc.2025.151325_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1535370215597194","article-title":"Epithelial-mesenchymal transition: an emerging target in tissue fibrosis","volume":"241","author":"Li","year":"2016","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.bbrc.2025.151325_bib21","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2025.151325_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/dvg.23529","article-title":"Epithelial-mesenchymal plasticity in kidney fibrosis","volume":"62","author":"Hadpech","year":"2024","journal-title":"Genesis"},{"key":"10.1016\/j.bbrc.2025.151325_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12967-019-1770-1","article-title":"In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells","volume":"17","author":"Masola","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbrc.2025.151325_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.151095","article-title":"Deubiquitinase inhibitor bAP-15 suppresses renal epithelial to mesenchymal transition via inhibition of p300 stability","volume":"741","author":"Kim","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2025.151325_bib25","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nm.3218","article-title":"Origin and function of myofibroblasts in kidney fibrosis","volume":"19","author":"LeBleu","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2025.151325_bib26","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1172\/JCI44595","article-title":"Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?","volume":"121","author":"Kriz","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2025.151325_bib27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.tem.2016.06.004","article-title":"Partial epithelial-to-mesenchymal transition and other new mechanisms of kidney fibrosis","volume":"27","author":"Lovisa","year":"2016","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.bbrc.2025.151325_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.569322","article-title":"New insights into the role and mechanism of partial epithelial-mesenchymal transition in kidney fibrosis","volume":"11","author":"Sheng","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbrc.2025.151325_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.molmed.2015.11.009","article-title":"Epithelial plasticity versus EMT in kidney fibrosis","volume":"22","author":"Huang","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbrc.2025.151325_bib30","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/med.20235","article-title":"Perspectives on medicinal properties of plumbagin and its analogs","volume":"32","author":"Padhye","year":"2012","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbrc.2025.151325_bib31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-3-319-41342-6_10","article-title":"Plumbagin and its role in chronic diseases","volume":"929","author":"Panichayupakaranant","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbrc.2025.151325_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/645727","article-title":"Plumbagin ameliorates CCl 4 -induced hepatic fibrosis in rats via the epidermal growth factor receptor signaling pathway","volume":"2015","author":"Chen","year":"2015","journal-title":"Evid. Based Complement Alternat Med."},{"key":"10.1016\/j.bbrc.2025.151325_bib33","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1159\/000373974","article-title":"Anti-fibrotic effect of plumbagin on CCl(4)-lesioned rats","volume":"35","author":"Wei","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbrc.2025.151325_bib34","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1089\/jmf.2019.4670","article-title":"Plumbagin suppresses pulmonary fibrosis via inhibition of p300 histone acetyltransferase activity","volume":"23","author":"Lee","year":"2020","journal-title":"J. Med. Food"},{"key":"10.1016\/j.bbrc.2025.151325_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13223-022-00734-7","article-title":"Plumbagin attenuates Bleomycin-induced lung fibrosis in mice","volume":"18","author":"Mehdizadeh","year":"2022","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"10.1016\/j.bbrc.2025.151325_bib36","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2174\/1389557520666201116144421","article-title":"Plumbagin: a potential anti-cancer compound","volume":"21","author":"Roy","year":"2021","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.151325_bib37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ame2.12194","article-title":"Folic acid-induced animal model of kidney disease","volume":"4","author":"Yan","year":"2021","journal-title":"Animal Model Exp. Med."},{"key":"10.1016\/j.bbrc.2025.151325_bib38","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1021\/acs.chemrestox.2c00258","article-title":"Higher concentrations of folic acid cause oxidative stress, acute cytotoxicity, and long-term fibrogenic changes in kidney epithelial cells","volume":"35","author":"Kandel","year":"2022","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbrc.2025.151325_bib39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev-physiol-052521-121841","article-title":"How many cell types are in the kidney and what do they do?","volume":"84","author":"Balzer","year":"2022","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbrc.2025.151325_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1545","article-title":"Crosstalk between fibroblasts and immunocytes in fibrosis: from molecular mechanisms to clinical trials","volume":"14","author":"Di","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbrc.2025.151325_bib41","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3390\/cells4040631","article-title":"Epithelial-to-Mesenchymal transition in diabetic nephropathy: fact or fiction?","volume":"4","author":"Loeffler","year":"2015","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2025.151325_bib42","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2025.151325_bib43","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/sj.bjc.6604662","article-title":"The role of endothelial-to-mesenchymal transition in cancer progression","volume":"99","author":"Potenta","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2025.151325_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107144","article-title":"The role of epithelial cells in fibrosis: mechanisms and treatment","volume":"202","author":"Luo","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2025.151325_bib45","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.matbio.2018.02.006","article-title":"Renal fibrosis: primacy of the proximal tubule","volume":"68\u201369","author":"Gewin","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bbrc.2025.151325_bib46","article-title":"Salidroside ameliorates renal interstitial fibrosis by inhibiting the TLR4\/NF-kappaB and MAPK signaling pathways","volume":"20","author":"Li","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.151325_bib47","article-title":"JMJD1A\/NR4A1 signaling regulates the procession of renal tubular epithelial interstitial fibrosis induced by AGEs in HK-2","volume":"8","author":"Wang","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.bbrc.2025.151325_bib48","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13020-022-00646-z","article-title":"Natural products: potential drugs for the treatment of renal fibrosis","volume":"17","author":"Zhou","year":"2022","journal-title":"Chin. Med."},{"key":"10.1016\/j.bbrc.2025.151325_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44177-5","article-title":"Periostin deficiency attenuates kidney fibrosis in diabetic nephropathy by improving pancreatic beta-cell dysfunction and reducing kidney EMT","volume":"13","author":"Cho","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.151325_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073428","article-title":"Plumbagin ameliorates diabetic nephropathy via interruption of pathways that include NOX4 signalling","volume":"8","author":"Yong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2025.151325_bib51","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1172\/JCI72267","article-title":"Cellular and molecular mechanisms in kidney fibrosis","volume":"124","author":"Duffield","year":"2014","journal-title":"J. Clin. Invest."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25000397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25000397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T01:54:50Z","timestamp":1740448490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25000397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":51,"alternative-id":["S0006291X25000397"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151325","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plumbagin ameliorates renal fibrosis by suppressing epithelial-mesenchymal transition","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151325"}}